TRIB
Trinity Biotech
TRIB
TRIB
23 hedge funds and large institutions have $9.66M invested in Trinity Biotech in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
23
Holding in Top 10
–
Calls
$4K
Puts
–
Top Buyers
| 1 | +$237K | |
| 2 | +$196K | |
| 3 | +$83.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.5K |
Top Sellers
| 1 | -$742K | |
| 2 | -$547K | |
| 3 | -$421K | |
| 4 |
ARM
Adirondack Research & Management
Guilderland,
New York
|
-$365K |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$115K |